ELVN vs HUBS · $2.11B cap vs P/E 96, rev $1.79B
Enliven Therapeutics Inc. (ELVN) versus HubSpot Inc (HUBS) — a side-by-side from cached financials, not a winner call.
Enliven Therapeutics Inc. (ELVN) is a biotechnology company listed on US.
HubSpot Inc (HUBS) is a software - application company listed on NYSE.
ELVN does not have a complete income-statement cache yet.
Latest reported HUBS revenue for 2026-06-30 was $1.79B. Net income was $75.9M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
ELVN currently screens at market cap $2.11B. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
Not investment advice. Open the ELVN and HUBS stock pages for the full models.
Not investment advice.